Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centralized safety monitoring of Kanglaite Injection in hospital practice
ChiCTR1900022813Phase 4Completed
- Sponsor
- Guang'anmen Hospital
- Start
- Apr 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of kanglaite in cancer, sponsored by Guang'anmen Hospital. Primary endpoint: Adverse event. Started Apr 2019; status: completed.
02
Drugs
kanglaite
03
Conditions
cancer
Beyond the preview
Go deeper on ChiCTR1900022813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022813.